Literature DB >> 9224907

Use of potentially abusive psychotropic substances in psychiatric inpatients.

J Modestin1, C Nussbaumer, K Angst, P Scheidegger, D Hell.   

Abstract

A series of 417 consecutively admitted psychiatric inpatients were studied with regard to their use of potentially abusive psychotropic substances in the last 3 months preceding admission. In all patients face-to-face interviews were performed; in 354 of them urine specimens could also be tested. Alcohol and benzodiazepines belonged to the most frequently used substances followed by cannabis, opiates and cocaine. Barbiturates, hallucinogens and amphetamine derivatives were only exceptionally reported. The most important finding of the study is that every fifth patient regularly used "hard" drugs (opiates and/or cocaine), every fourth patient illegal drugs and every third patient alcohol. Substances were found in 54% of all urine specimens; methadone, opiates and cocaine were hardly found alone. For the latter substances excellent agreement was found between interview reports and urine exams. Excluding patients diagnosed as substance-use disorders, there were no statistically significant differences between schizophrenic, affective, neurotic/stress/somatoform and other disorders with regard to the use of "hard" drugs and illegal drugs. Regular substance use correlated with much worse psychosocial adjustment. Substance use has to be explored and considered in every individual psychiatric inpatient.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224907     DOI: 10.1007/bf03033068

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  52 in total

1.  Manic-depressive psychosis and drug abuse.

Authors:  N El-Guebaly
Journal:  Can Psychiatr Assoc J       Date:  1975-12

2.  Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County.

Authors:  S Andréasson; P Allebeck; U Rydberg
Journal:  Acta Psychiatr Scand       Date:  1989-05       Impact factor: 6.392

3.  Reliability and validity of the Westminster Substance Use Questionnaire among Lancashire adolescents.

Authors:  M L Adelekan; S Gowers; D Singh
Journal:  Drug Alcohol Depend       Date:  1994-02       Impact factor: 4.492

4.  Psychopathology in drug abusers and their families.

Authors:  S M Mirin; R D Weiss; M L Griffin; J L Michael
Journal:  Compr Psychiatry       Date:  1991 Jan-Feb       Impact factor: 3.735

5.  Unrecognized cocaine use among schizophrenic patients.

Authors:  A Shaner; M E Khalsa; L Roberts; J Wilkins; D Anglin; S C Hsieh
Journal:  Am J Psychiatry       Date:  1993-05       Impact factor: 18.112

6.  Symptom severity and utilization of treatment resources among dually diagnosed inpatients.

Authors:  R Ries; M Mullen; G Cox
Journal:  Hosp Community Psychiatry       Date:  1994-06

Review 7.  Dual diagnosis.

Authors:  M F Sheehan
Journal:  Psychiatr Q       Date:  1993

8.  Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.

Authors:  L Dixon; P J Weiden; G Haas; J Sweeney; A J Frances
Journal:  Compr Psychiatry       Date:  1992 Mar-Apr       Impact factor: 3.735

Review 9.  The relationship between substance abuse and bipolar disorder.

Authors:  K T Brady; S C Sonne
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

10.  Substance abuse in an inpatient psychiatric sample.

Authors:  K Brady; S Casto; R B Lydiard; R Malcolm; G Arana
Journal:  Am J Drug Alcohol Abuse       Date:  1991       Impact factor: 3.829

View more
  4 in total

1.  Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.

Authors:  Matthew M Large; Glen Smith; Grant Sara; Michael B Paton; Karina Karolina Kedzior; Olav B Nielssen
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-27       Impact factor: 4.035

2.  Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder?

Authors:  Jules Angst; Alex Gamma; Jérôme Endrass; Wulf Rössler; Valdeta Ajdacic-Gross; Dominique Eich; Richard Herrell; Kathleen Ries Merikangas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-17       Impact factor: 5.270

3.  Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Authors:  Anne-Marit Langås; Ulrik F Malt; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2011-02-12       Impact factor: 3.630

Review 4.  Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.

Authors:  Henk S Temmingh; Taryn Williams; Nandi Siegfried; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2018-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.